DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
R-p Mycin is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in R-P MYCIN is erythromycin. There are one hundred and three drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
A generic version of R-P MYCIN was approved as erythromycin by TORRENT on July 6th, 2020.
Anatomical Therapeutic Chemical (ATC) Classes for R-P MYCIN
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Solvay||R-P MYCIN||erythromycin||TABLET, DELAYED RELEASE;ORAL||061659-001||Approved Prior to Jan 1, 1982||DISCN||No||No||⤷ Free Forever Trial||⤷ Free Forever Trial||⤷ Free Forever Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|